Compare VTSI & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VTSI | IXHL |
|---|---|---|
| Founded | 1993 | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.9M | 49.1M |
| IPO Year | N/A | N/A |
| Metric | VTSI | IXHL |
|---|---|---|
| Price | $4.88 | $0.43 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | 56.0K | ★ 24.4M |
| Earning Date | 11-10-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $24,934,267.00 | $12,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $13.39 | N/A |
| P/E Ratio | $341.38 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.57 | $0.08 |
| 52 Week High | $7.49 | $2.25 |
| Indicator | VTSI | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 44.34 | 57.78 |
| Support Level | $4.81 | $0.38 |
| Resistance Level | $5.13 | $0.50 |
| Average True Range (ATR) | 0.13 | 0.04 |
| MACD | 0.03 | 0.01 |
| Stochastic Oscillator | 44.09 | 65.18 |
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.